ArticleMaternal and child health journal2017
The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts.
Article in Maternal and child health journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.
- Substance use during pregnancy and risk of postpartum depression: a systematic review and meta-analysis.Frontiers in psychiatry · 2023Pooled it
- A Novel 4D Ultrasound Parenting Intervention for Substance Using Pregnant Women in Finland: Participation in Obstetric Care, Fetal Drug Exposure, and Perinatal Outcomes in a Randomized Controlled Trial.Maternal and child health journal · 2020Trial
- Prevalence of substance use during pregnancy in New Jersey: Investigating the effects of the COVID-19 public health emergency.Drug and alcohol dependence reports · 2026Article
- Adverse Pregnancy Outcomes with Co-Occurring Opioid and Stimulant Use Disorders.Journal of clinical medicine · 2026Article
- Understanding Barriers to Disclosure of and Treatment for Substance Use During Pregnancy: A Narrative Synthesis of Literature.Journal of pregnancy · 2026Review
- Recovering Together: The Socioecological Impact of Social Networks on Postpartum Substance Use Disorder Recovery.Community mental health journal · 2025Article
- Engagement With Recommended Developmental Follow-up and Supports Among Infants With Intrauterine Opioid Exposure.Journal of developmental and behavioral pediatrics : JDBP · 2025Article
- Breastfeeding Continuation at One Month Postpartum Among Women in Treatment for Opioid Use Disorder Who Initiated Breastfeeding: Prevalence and Determinants.Women's health reports (New Rochelle, N.Y.) · 2025Article
- Maternal mental disorders and neonatal outcomes: Danish population-based cohort study.The British journal of psychiatry : the journal of mental science · 2025Article
- A credibility-driven evaluation of a community-based perinatal substance use disorder collaborative care model.Frontiers in public health · 2025Article
- Perinatal substance use disorder: Examining the impact on adverse pregnancy outcomes.European journal of obstetrics & gynecology and reproductive biology: X · 2024Article
- Chronic Opioid Treatment Arrests Neurodevelopment and Alters Synaptic Activity in Human Midbrain Organoids.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Breastfeeding Intention, Knowledge, and Attitude of Pregnant Women in Treatment for Opioid Use Disorder.American journal of perinatology · 2024Article
- Philadelphia Department of Health Doula Support Program: Early Successes and Challenges of a Program Serving Birthing People Affected by Substance Use Disorder.Maternal and child health journal · 2023Article
- Maternal and Neonatal Outcomes in Women with Metabolic Syndrome and Substance Use Disorder.Life (Basel, Switzerland) · 2023Article
- Impact of an Asynchronous Training for the Early Intervention and Childcare Workforce Addressing the Developmental Impact of the Opioid Crisis on Young Children.Maternal and child health journal · 2023Review
- Usability and acceptability testing of a Plan of Safe Care in a mobile health platform.Frontiers in psychiatry · 2023Article
- Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective.Frontiers in pediatrics · 2023Review
- The association between asthma and perinatal mental illness: a population-based cohort study.International journal of epidemiology · 2022Article
- Association of prenatal substance use with prenatal and postpartum care: Evidence from the Pregnancy Risk Assessment Monitoring System, 2016-2019.Preventive medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
Abstract
Objectives Despite widely-known negative effects of substance use disorders (SUD) on women, children, and society, knowledge about population-based prevalence and impact of SUD and SUD treatment during the perinatal period is limited. Methods Population-based data from 375,851 singleton deliveries in Massachusetts 2003-2007 were drawn from a maternal-infant longitudinally-linked statewide dataset of vital statistics, hospital discharges (including emergency department (ED) visits), and SUD treatment records. Maternal SUD and SUD treatment were identified from 1-year pre-conception through delivery. We determined (1) the prevalence of SUD and SUD treatment; (2) the association of SUD with women's perinatal health service utilization, obstetric experiences, and birth outcomes; and (3) the association of SUD treatment with birth outcomes, using both bivariate and adjusted analyses. Results 5.5% of Massachusetts's deliveries between 2003 and 2007 occurred in mothers with SUD, but only 66% of them received SUD treatment pre-delivery. Women with SUD were poorer, less educated and had more health problems; utilized less prenatal care but more antenatal ED visits and hospitalizations, and had worse obstetric and birth outcomes. In adjusted analyses, SUD was associated with higher risk of prematurity (AOR 1.35, 95% CI 1.28-1.41) and low birth weight (LBW) (AOR 1.73, 95% CI 1.64-1.82). Women receiving SUD treatment had lower odds of prematurity (AOR 0.61, 95% CI 0.55-0.68) and LBW (AOR 0.54, 95% CI 0.49-0.61). Conclusions for Practice SUD treatment may improve perinatal outcomes among pregnant women with SUD, but many who need treatment don't receive it. Longitudinally-linked existing public health and programmatic records provide opportunities for states to monitor SUD identification and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.